New York, NY – 7/01/2016. DermaClip® today announced the appointment of Dr. Jeffrey S. Freed, MD, FACS, FACG, to its Medical Advisory Board and named him Chairman of that Board. Dr. Freed is an Associate Professor of Surgery at Mt. Sinai Hospital in New York City, the Branch Chief of Colorectal Surgery at the Bronx VA Hospital, and a dedicated an experienced and recognized clinician, and a dedicated humanitarian that frequently travels on missions to third-world countries to perform needed surgeries in underserved communities. In addition, he successfully founded a care company that went on to establish a national presence that was ultimately bought out by a major health company. His appointment brings a depth of knowledge and experience both on the medical and on the business side as we move forward in introducing the DermaClip® Skin Closure Device into the US market.
DermaClip® is a revolutionary, new non-invasive skin closure device made of hypoallergenic adhesive coupled with a polypropylene bridge that allows for the quick and easy closure of surface wounds and the final stage of surgical incisions. With no puncturing or crushing of the skin, the patented single-use, needle-less device is designed to evert the skin on every closure to promote healthy healing while being quick and easy-to-use.
The DermaClip® team believes that high quality skin closure should be available to everyone, regardless of access to high-end services. The team aims to eliminate the trade-offs in skin closure made between time of closure and quality of patient care.
The US operations of DermaClip® are owned and operated by DermaClip® US, L.L.C., a Texas based company.